×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 8: Compliance Update Panel
Session Chair(s)
Scott Liebman
Partner
Loeb & Loeb, LLP, United States
From drug pricing to First Amendment questions and completion of Corporate Integrity Agreements, companies are facing new and challenging compliance issues. This panel will explore these new trends and offer insight on how to navigate the uncertainty.
Speaker(s)
Panelists
Joe Zimmerman
Actavis & Forest, United States
Former Senior Vice President, Chief Compliance Officer
Emily Wright, JD
Emily Wright, JD
Pfizer, United States
Senior Corporate Counsel
Howard L. Dorfman, JD
Howard L. Dorfman, JD
H. L. Dorfman Pharmaceutical Consulting, United States
Founder
Have an account?